Univariable | Multivariable | Multivariable | ||||
---|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
TSR | ||||||
Low | Reference | Reference | Reference | |||
High | 2.12 (1.06–4.23) | 0.033 | 2.19 (1.09–4.42) | 0.028 | 2.20 (1.10–4.44) | 0.027 |
BRAF | ||||||
Wildtype (wt) | Reference | Reference | ||||
Mutant (mt) | 2.70 (1.30–5.61) | 0.008 | 2.11 (0.97–4.59) | 0.061 | NI | |
KRAS | ||||||
Wildtype (wt) | Reference | |||||
Mutant (mt) | 1.00 (0.49–2.04) | 0.996 | NI | NI | ||
Microsatellite | ||||||
Stable (MSS) | Reference | Reference | ||||
Instable (MSI) | 2.53 (1.24–5.17) | 0.011 | NI | 1.79 (0.81–3.99) | 0.152 | |
Age | 1.01 (0.98–1.05) | 0.433 | NI | NI | ||
Gender | ||||||
Male | Reference | |||||
Female | 1.65 (0.80–3.41) | 0.174 | NI | NI | ||
Comorbidities | ||||||
0 | Reference | |||||
1 | 2.34 (0.99–5.53) | 0.052 | ||||
≥ 2 | 2.48 (0.79–7.82) | 0.121 | NI | NI | ||
Surgery | ||||||
Elective | Reference | |||||
Acute | 1.63 (0.48–5.47) | 0.431 | NI | NI | ||
Tumour localisation | ||||||
Right colon | Reference | |||||
Left colon | 0.92 (0.46–1.81) | 0.800 | NI | NI | ||
TNM stage | ||||||
I | Reference | |||||
II | 0.71 (0.29–1.72) | 0.445 | NI | NI | ||
Differentiation | ||||||
Well/Moderate | Reference | Reference | Reference | |||
Poor/Undifferentiated | 3.28 (1.56–6.90) | 0.002 | 2.59 (1.16–5.76) | 0.020 | 2.53 (1.10–5.82) | 0.029 |
Lymph-angio invasion | ||||||
No | Reference | |||||
Yes | 1.11 (0.46–2.69) | 0.814 | NI | NI |